Women Health Diagnostics Market: Current Analysis and Forecast (2021-2027)

$3500$6860

Emphasis on Applications (Breast Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Prenatal Testing), End-User (Diagnostics Centers, Hospitals, Homecare); and Region & Country.

Pages:

162

Table:

64

Figure:

91

Report ID:

UMHE21294

Geography:

Clear
  Get a Free Sample
SKU: UMHE21294 Category:
Report Description
Table of content
Research Methodology

Report Description

Women are more susceptible to certain diseases such as menstrual disorders, cancer, osteoporosis, sexual disorders, and autoimmune diseases. The major diseases include cervical cancer, breast cancer, infertility, menopause, and polycystic ovarian syndrome (PCOS). As per the Centers for Disease Control and Prevention, PCOS is one of the most common causes of female infertility, affecting 6% to 12% (as many as 5 million) of US women of reproductive age.

The demand for Women’s Health Diagnostics is mainly increasing on account of the increasing incidence of chronic and lifestyle disorders, rising awareness regarding various health-related disorders, high prevalence of infectious diseases such as hepatitis and HIV in women all over the world. Moreover, the rising number of diagnostic and imaging centers and the high adoption of POC diagnostic testing also propel market growth. As per the Joint United Nations Program on HIV and AIDS 2020, women and girls accounted for about 50% of all new HIV infections in 2020 while in sub-Saharan Africa, women and girls accounted for 63% of all new HIV infections.

Global Incident Rates of Cancer in Women of All Ages, 2020

Some of the major players operating in the market include Abbott Laboratories, Becton, Dickinson, and Company, Biomerieux SA, Carestream Health, Hoffmann-La Roche AG, GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Mankind Pharma, and Siemens AG. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Insights Presented in the Report

“Amongst Applications, Breast Cancer Testing segment holds the major share.”

Based on Applications, the market is fragmented into Breast Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, and Prenatal Testing. Breast Cancer Testing holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to increasing breast cancer cases and rising awareness about advanced breast cancer diagnostic techniques, such as Automated Breast Ultrasonography (ABUS) which allows three-dimensional representation of breast tissue and allows images reformatting in 3D. Moreover, women suffering from breast cancer are more prone to getting affected by the COVID-19 infection. As per breastcancer.org, approximately 281,550 new cases of invasive breast cancer and 49,290 new cases of non-invasive (in situ) breast cancer are estimated to be diagnosed in women in the U.S. in 2021.

“Amongst End-user, Homecare is anticipated to grow at the highest CAGR during the analyzed period.”

Based on End-user, the market is fragmented into Diagnostics Centers, Hospitals, and Homecare. The home care segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period due to the rising incidents of infectious diseases which has resulted in increased use of self-testing kits. The self-testing kits allow the patients to manage their diseases by utilizing these kits. Furthermore, Technological advancements have made many self-testing kits available for various conditions, such as pregnancy and ovulation. For instance, the Prega News Pregnancy Kit developed by Mankind Pharmaceuticals Ltd uses a sera reagent that will detect Human chorionic gonadotropin (HCG) content in a woman’s urine, signifying whether a woman is pregnant or not remotely.

“North America signifies one of the largest markets and Europe is expected to be the fastest-growing markets of Women Health Diagnostics market.”

For a better understanding of the market adoption of Women Health Diagnostics, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Women Health Diagnostics market on account of the rising prevalence of infectious diseases amongst women, increasing adoption of technologically advanced products, and rising government initiatives. In 2021, Hologic, Inc., a global leader in women’s health, acquired Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately US$ 230 million, to strengthen its presence in the women’s health diagnostics market.

 

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

Women Health Diagnostics market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Objective of the Study
1.3.Limitation
1.4.Stake Holders
1.5.Currency Used in Report
1.6.Scope of the Global Women Health Diagnostics Market Study
2.1.Research Methodology for the Global Women Health Diagnostics Market
 2.1.1.Main Objective of the Global Women Health Diagnostics Market
3MARKET SYNOPSIS
5GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET REVENUE (USD BN), 2019-2027F
6.1.Breast Cancer Testing 
6.2.Infectious Disease Testing
6.3.Osteoporosis Testing
6.4.Pregnancy and Fertility Testing
6.5.Prenatal Testing
7MARKET INSIGHTS BY END-USER
7.1.Diagnostics Centers
7.2.Hospitals 
7.3.Homecare
8.1.North America Women Health Diagnostics Market 
 8.1.1.United States
 8.1.2.Canada
 8.1.3.Rest of North America
8.2.Europe Women Health Diagnostics Market 
 8.2.1.Germany
 8.2.2.France
 8.2.3.United Kingdom
 8.2.4.Italy
 8.2.5.Spain
 8.2.6.Rest of Europe
8.3.Asia Pacific Women Health Diagnostics Market
 8.3.1.China
 8.3.2.Japan
 8.3.3.India
 8.3.4.Australia
 8.3.5.Rest of Asia Pacific
8.4.Rest of the World Women Health Diagnostics Market
DEMAND AND SUPPLY SIDE ANALYSIS
9.1.Demand Side Analysis
9.2.Supply Side Analysis
 9.2.1.Top Product Launches
 9.2.2.Top Business Partnerships
 9.2.3.Top Business Expansions, Investments and Divestitures
 9.2.4.Top Merger and Acquisitions
9.1.Demand Side Analysis
9.2.Supply Side Analysis
 9.2.1.Top Product Launches
 9.2.2.Top Business Partnerships
 9.2.3.Top Business Expansions, Investments and Divestitures
 9.2.4.Top Merger and Acquisitions
10VALUE CHAIN ANALYSIS
11GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET TRENDS & INSIGHTS
12.1.Market Drivers
12.2.Market Challenges
12.3.Impact Analysis
13GLOBAL WOMEN HEALTH DIAGNOSTICS MARKET OPPORTUNITIES
14.1.Porter’s Five Forces Analysis
 14.1.1.Bargaining power of Supplier
 14.1.2.Bargaining power of Buyer
 14.1.3.Industry Rivalry
 14.1.4.Availability of Substitute
 14.1.5.Threat of new Entrants
15.1.Abbott Laboratories
15.2.Becton, Dickinson and Company
15.3.Biomerieux SA
15.4.Carestream Health
15.5.Hoffmann-La Roche AG
15.6.GE Healthcare
15.7.Hologic, Inc.
15.8.Koninklijke Philips N.V.
15.9.Mankind Pharma
15.10.Siemens AG
16DISCLAIMER

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Women Health Diagnostics market were the three major steps undertaken to create and analyze the adoption of Women Health Diagnostics for the different applications across major End-users such as Diagnostics Centers, Hospitals, and Homecare. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Women Health Diagnostics sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to.

Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the Women Health Diagnostics through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Women Health Diagnostics market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are Applications, End-user, and Region. Further country-level analyses were conducted to evaluate the overall adoption of Women’s Health Diagnostics in every region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Women Health Diagnostics. Further, we conducted factor analysis using dependent and independent variables such as increasing incidence of chronic and lifestyle disorders, rising awareness regarding various health-related disorders, high prevalence of infectious diseases such as hepatitis and HIV in women.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Women Health Diagnostics  Market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (USD) and the adoption rate of Women Health Diagnostics across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the Women Health Diagnostics market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Women Health Diagnostics market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of Applications, End-user, and Region of the Women’s Health Diagnostics market.

Main Objective of the Women Health Diagnostics Market Study

The current & future market trends of Women’s Health Diagnostics were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of Women Health Diagnostics in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments.
  • Segments in the study include areas of Applications, End-user, and Region
  • Define and analysis of the regulatory framework for the Women Health Diagnostics industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the Women Health Diagnostics market for the major region
  • Major regions studied in the report include North America (the United States and Canada), Europe (Germany, France, Italy, Spain, and United Kingdom), Asia-Pacific (China, Japan, India, and Australia), and Rest of the World
  • Company profiles of the Women Health Diagnostics market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry